Discover the potential of macrocycles in drug discovery: flexible, cell-permeable molecules targeting undruggable proteins.

Biomedical engineers at Duke University have developed an AI-based platform that designs short proteins, termed peptides, ...

Drugs targeting amyloid plaques have failed to show efficacy in clinical trials. A new approach is needed to tackle AD ...

The Kowalinski group at EMBL Grenoble discovered notable differences between the nuclear cap-binding complex in trypanosomes and humans, a critical component in cellular RNA metabolism. Trypanosomes ...

With continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.

Jefferies reaffirmed its Buy rating on Alkermes (NASDAQ:ALKS) shares, maintaining a price target of $41.00. Currently trading at $31.80 and near its 52-week high of $32.88, the stock has shown strong ...

In a recent series of transactions, Matthew Shair, a director at Nuvalent , Inc. (NASDAQ:NUVL), a $6.08 billion market cap company, sold a total of 2,000 shares of Class A Common Stock. The sales, ...

What do drugs target to relieve anxiety ... and the prefrontal cortex (PFC)—are all subject to lasting shifts in structure and function as a result of the disorder. Most notably, the amygdala ...

Investigators have identified in a preclinical model a specific brain circuit whose inhibition appears to reduce anxiety without side effects. Their work suggests a new target for treating anxiety ...

Researchers at Tel Aviv University have achieved a breakthrough in drug delivery: they have successfully transported lipid ...

University of Kentucky Markey Cancer Center researchers have discovered a promising new way to combat therapy-resistant ...

Structure Therapeutics, Inc. Sponsored ADR (GPCR – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst ...